Research interests
During residency, studied the intersection of sex and hypertension.[12]
MT
Interventional Cardiology Fellowship at Duke University Hospital, completed in 2026.
As of 2026 · Last known relationship
Manasi Tannu is an interventional cardiologist whose clinical and research work connects catheter-based cardiovascular care with treatment equity and anticoagulation questions. She earned her medical degree at the University of North Carolina at Chapel Hill, completed internal medicine training at Emory, and completed cardiovascular disease and interventional cardiology fellowships at Duke University Hospital through 2026. She also holds a Master of Public Health from the UNC Gillings School of Public Health and is board certified in internal medicine and cardiovascular disease. Her research has examined sex and hypertension, randomized cardiovascular trials, evidence-based diabetes care across demographic groups, antithrombotic therapy after ACS or PCI, and intracranial hemorrhage in atrial fibrillation. She practices with Georgia Heart Institute in Gainesville, Georgia.
Each topic is linked to its supporting source in Sources.
Training includes Interventional Cardiology Fellowship at Duke University Hospital, completed in 2026., Medical school at the University of North Carolina at Chapel Hill, completed in 2017., Attended the University of North Carolina at Chapel Hill for university or college., and Board certified in Cardiovascular Disease by the American Board of Internal Medicine in 2024., plus 7 more records.
Explore education and trainingAs of 2026
2025
As of 2017
During residency, studied the intersection of sex and hypertension.[12]
Named as a coauthor of work on the COORDINATE-Diabetes intervention and evidence-based cardiovascular care.[11]
2024
Presented “Intracranial Hemorrhage in Patients with Atrial Fibrillation: Insights from COMBINE-AF” at the European Society of Cardiology COMBINE-AF Meeting on August 31, 2024.[13]
2024
Presented the COORDINATE-Diabetes subgroup analysis at the American College of Cardiology Scientific Sessions in March 2024.[11]
2024
Presenter of a presentation on antithrombotic strategies and outcome events in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention.[14]
2023
Research portfolio includes randomized trials such as ARTEMIS and V-INTERVENTION and anticoagulation in cardiovascular disease.[12]
Research topic on intracranial hemorrhage in patients with atrial fibrillation, with insights from COMBINE-AF.[13]
2024